World's Best Scientists 2026 revealed!
Mahmood Jeddi-Tehrani

Mahmood Jeddi-Tehrani

D-Index & Metrics

Biology and Biochemistry

D-Index
47
Citations
7480
World Ranking
18742
National Ranking
20

Mahmood Jeddi-Tehrani publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Mahmood Jeddi-Tehrani sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 293 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Mahmood Jeddi-Tehrani D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Mahmood Jeddi-Tehrani sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 47 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Mahmood Jeddi-Tehrani is affiliated with the Avicenna Research Institute in Iran and has a research profile spanning multiple fields within medicine and biological sciences. Their work covers a wide spectrum of study areas focusing on molecular biology, immunology, and oncology, with additional attention to radiology and infectious diseases.

The scientist's publication record features significant contributions in primary fields of study including:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology
  • Immunology and Microbiology

Within these areas, they have explored several important subfields, such as:

  • Molecular Biology
  • Immunology
  • Radiology, Nuclear Medicine and Imaging
  • Oncology
  • Infectious Diseases

The topics Mahmood Jeddi-Tehrani has extensively researched include:

  • Monoclonal and Polyclonal Antibodies Research
  • HER2/EGFR in Cancer Research
  • SARS-CoV-2 and COVID-19 Research
  • Reproductive System and Pregnancy
  • Glycosylation and Glycoproteins Research
  • Hepatitis B Virus Studies
  • Immunotherapy and Immune Responses

The scientist has published in various well-known venues with multiple papers in:

  • PubMed
  • Frontiers in Immunology
  • Avicenna Journal of Medical Biotechnology
  • Viral Immunology
  • International Immunopharmacology

Frequent collaborators in their research include:

  • Mohammad Mehdi Amiri
  • Forough Golsaz-Shirazi
  • Amir-Hassan Zarnani
  • Fazel Shokri
  • Tannaz Bahadori

Recent notable publications by Mahmood Jeddi-Tehrani include:

  • Placenta: an old organ with new functions, 2024, Frontiers in Immunology
  • A Novel Anti-HER2 Bispecific Antibody With Potent Tumor Inhibitory Effects In Vitro and In Vivo, 2021, Frontiers in Immunology
  • Myeloid-derived suppressor cells (MDSCs) depletion by cabozantinib improves the efficacy of anti-HER2 antibody-based immunotherapy in a 4T1-HER2 murine breast cancer model, 2022, International Immunopharmacology
  • Identification of immunodominant epitopes on nucleocapsid and spike proteins of the SARS-CoV-2 in Iranian COVID-19 patients, 2022, Pathogens and Disease
  • Proteome profiling of human placenta reveals developmental stage-dependent alterations in protein signature, 2021, Clinical Proteomics

Best Publications

  • Idiotype Immunization Combined With Granulocyte-Macrophage Colony-Stimulating Factor in Myeloma Patients Induced Type I, Major Histocompatibility Complex–Restricted, CD8- and CD4-Specific T-Cell Responses

    Anders Österborg;Qing Yi;Lotta Henriksson;Jan Fagerberg

  • Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy.

    Amir H. DaneshManesh;Eva Mikaelsson;Mahmood Jeddi‐Tehrani;Ali Ahmad Bayat

  • The citrus flavonoid hesperidin induces p53 and inhibits NF-κB activation in order to trigger apoptosis in NALM-6 cells: involvement of PPARγ-dependent mechanism.

    Asghar Ghorbani;Maryam Nazari;Mahmood Jeddi-Tehrani;Hamid Zand

  • Extraction, Purification and Characterization of Lipopolysaccharide from Escherichia coli and Salmonella typhi

    Simin Rezania;Noor Amirmozaffari;Bahman Tabarraei;Mahmood Jeddi-Tehrani

  • Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells.

    Daneshmanesh Ah;Hojjat-Farsangi M;Khan As;Jeddi-Tehrani M;Jeddi-Tehrani M

  • Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating Factor

    Gustav J. Ullenhag;Jan-Erik Frödin;Mahmood Jeddi-Tehrani;Karin Strigård

  • Oligoclonal TCRBV gene usage in B-cell chronic lymphocytic leukemia: major perturbations are preferentially seen within the CD4 T-cell subset.

    Mohammad-Reza Rezvany;Mahmood Jeddi-Tehrani;Anders Österborg;Eva Kimby

  • Thrombophilic mutations in Iranian patients with infertility and recurrent spontaneous abortion

    Reza Behjati;Mohammad Hossein Modarressi;Mahmood Jeddi-Tehrani;Pouneh Dokoohaki

  • Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment.

    Reyhaneh Varshochian;Mohammad Riazi-Esfahani;Mahmood Jeddi-Tehrani;Ahmad-Reza Mahmoudi

  • Analysis of plasminogen activator inhibitor-1, integrin beta3, beta fibrinogen, and methylenetetrahydrofolate reductase polymorphisms in Iranian women with recurrent pregnancy loss.

    Mahmood Jeddi-Tehrani;Raheleh Torabi;Amir H. Zarnani;Amir H. Zarnani;Afsaneh Mohammadzadeh

  • Expression profiling of vitamin D receptor in placenta, decidua and ovary of pregnant mice.

    M. Shahbazi;M. Jeddi-Tehrani;M. Jeddi-Tehrani;M. Zareie;A. Salek-Moghaddam

  • Menstrual blood-derived stromal stem cells from women with and without endometriosis reveal different phenotypic and functional characteristics

    Shohreh Nikoo;Massoumeh Ebtekar;Mahmood Jeddi-Tehrani;Adel Shervin

  • Isolation, identification, and culture of goat spermatogonial stem cells using c-kit and PGP9.5 markers

    Banafsheh Heidari;Maryam Rahmati-Ahmadabadi;Mohammad Mehdi Akhondi;Amir Hassan Zarnani

  • Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia.

    Mohammad-Reza Rezvany;Mahmood Jeddi-Tehrani;Hans Wigzell;Anders Österborg

  • Vitamin D3 receptor is expressed in the endometrium of cycling mice throughout the estrous cycle

    Amir Hassan Zarnani;Mehdi Shahbazi;Alireza Salek-Moghaddam;Mehri Zareie

  • The protective effect of albumin on bevacizumab activity and stability in PLGA nanoparticles intended for retinal and choroidal neovascularization treatments.

    Reyhaneh Varshochian;Mahmood Jeddi-Tehrani;Ahmad Reza Mahmoudi;Mohammad Reza Khoshayand

  • Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies

    Amir Hossein Daneshmanesh;Anna Porwit;Mohammad Hojjat-Farsangi;Mahmood Jeddi-Tehrani

  • T cell repertoire in patients with multiple myeloma and monoclonal gammopathy of undetermined significance-Clonal CD8+ T cell expansions are found preferentially in patients with a low tumor burden.

    Eva Halapi;Åsa Werner;Jan Wahlström;Anders Österborg

  • Diminished Th1 and Th2 cytokine production in healthy adult nonresponders to recombinant hepatitis B vaccine.

    G. A. Kardar;M. Jeddi-Tehrani;F. Shokri;F. Shokri

  • EUTOPIC AND ECTOPIC STROMAL CELLS FROM PATIENTS WITH ENDOMETRIOSIS EXHIBIT DIFFERENTIAL INVASIVE, ADHESIVE, AND PROLIFERATIVE BEHAVIOR

    Ali-Akbar Delbandi;Mahmoud Mahmoudi;Adel Shervin;Elham Akbari

Frequent Co-Authors

Håkan Mellstedt
Håkan Mellstedt Karolinska Institute
Anders Österborg
Anders Österborg Karolinska Institute
Johan Grunewald
Johan Grunewald Karolinska University Hospital
Rassoul Dinarvand
Rassoul Dinarvand Tehran University of Medical Sciences
Mohammad Reza Yaghoobi-Ershadi
Mohammad Reza Yaghoobi-Ershadi Tehran University of Medical Sciences
Farhad Jadidi-Niaragh
Farhad Jadidi-Niaragh Tabriz University of Medical Sciences
Hans Wigzell
Hans Wigzell Karolinska Institute
Abbas Mirshafiey
Abbas Mirshafiey Tehran University of Medical Sciences
Asghar Aghamohammadi
Asghar Aghamohammadi Tehran University of Medical Sciences
Yavar Rassi
Yavar Rassi Tehran University of Medical Sciences

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Biology and Biochemistry in the USA, there are diverse career and degree options available. Many students explore allied health fields, such as medical billing and coding, which offers a flexible path with a strong job outlook. If you’re wondering how long does it take to become a medical coder, it typically requires short-term training, making it an attractive option for quick entry into the workforce.

The medical billing and coding job outlook is positive, with growing demand in healthcare settings and opportunities for remote work. For those seeking to advance further, there are affordable online HIM programs that can open doors to management positions in health information.

Another pathway is nutrition, where scientific backgrounds are highly valued. Students interested in this area can find reputable online degrees in nutrition that offer flexibility and affordability. These options help turn a passion for science into a meaningful career in healthcare, wellness, or administration.

Best Scientists Citing Mahmood Jeddi-Tehrani

Trending Scientists

Recently Published Articles